- Fragoso-Negrín J-A, Vergara-Gil A, Rahman Hakim A, Hardiansyah D, Glatting G, Ferrer L, Varmenot N, Santoro L, Veloza-Awad S, Hébert K, Deshayes E, Bardiès M. OpenDose3D: A Free, Open-Source Clinical Dosimetry Software for Patient-Specific Dosimetry. J Nucl Med 2026; epub 2025: jnumed.125.269539.
- Hakim AR, Hardiansyah D, Yousefzadeh-Nowshahr E, Nemer U, Ritawidya R, Kind F, Beer AJ, Meyer PT, Glatting G, Mix M. Accuracy and precision of few-time-points renal dosimetry for [177Lu]Lu-PSMA-617 therapy: Analysis with nonlinear mixed-effects modeling. Med Phys 2026; 53(1): e70212.
- Hardiansyah D, Patrianesha BB, Shi K, Saboury B, Rahmim A, Glatting G. An Overview of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Models: Applications to Radiopharmaceutical Therapies for Analysis and Personalization. PET Clin 2026; 21(1): 89-100.
- Kratzer W, Steinkellner S, Skotnik D, Peters L, Gruener B, Eberhardt N. Diagnosis of hepatic alveolar echinococcosis:18F-FDG-PET activity compared to the Echinococcus multilocularis Ulm Ultrasound Classification. Nuklearmedizin 2026; 65: 4-12
- Ryhiner M, Song Y, Saboury B, Glatting G, Rahmim A, Shi K. Mathematical and Computational Nuclear Oncology: Toward Optimized Radiopharmaceutical Therapy via Digital Twins. PET Clin 2026; 21(1): 117-131.
- Vasić V, Gustafsson J, Yousefzadeh-Nowshahr E, Beer AJ, Sjögreen Gleisner K, Glatting G. [177Lu]Lu-DOTA-TATE tumour and organ timeactivity curves: prediction from a single-time-point [68Ga]Ga-DOTA-TATE PET/CT measurement. EJNMMI Phys 2026; epub 16.01.2026
